×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IBIO – ibio, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IBIO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/25
08:10 am
ibio
iBio Strengthens Board with Appointment of Two New Independent Directors [Yahoo! Finance]
Medium
Report
iBio Strengthens Board with Appointment of Two New Independent Directors [Yahoo! Finance]
11/25
08:00 am
ibio
iBio Strengthens Board with Appointment of Two New Independent Directors
Medium
Report
iBio Strengthens Board with Appointment of Two New Independent Directors
11/22
07:04 am
ibio
AiAdvertising Announces CFO Transition in Preparation for Nasdaq Uplisting [Yahoo! Finance]
Medium
Report
AiAdvertising Announces CFO Transition in Preparation for Nasdaq Uplisting [Yahoo! Finance]
11/12
04:05 pm
ibio
iBio Reports Fiscal First Quarter 2025 Financial Results
Medium
Report
iBio Reports Fiscal First Quarter 2025 Financial Results
10/10
08:00 am
ibio
iBio and AstralBio Provide Update on Myostatin Program for Obesity
Medium
Report
iBio and AstralBio Provide Update on Myostatin Program for Obesity
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/9
05:08 pm
ibio
Form 4 iBio, Inc. For: Nov 21 Filed by: Parada Antonio Bernardino Guimaraes
Medium
Report
Form 4 iBio, Inc. For: Nov 21 Filed by: Parada Antonio Bernardino Guimaraes
12/9
05:07 pm
ibio
Form 3 iBio, Inc. For: Nov 21 Filed by: Parada Antonio Bernardino Guimaraes
Medium
Report
Form 3 iBio, Inc. For: Nov 21 Filed by: Parada Antonio Bernardino Guimaraes
11/25
04:34 pm
ibio
Form 4 iBio, Inc. For: Nov 21 Filed by: Sender Gary
Low
Report
Form 4 iBio, Inc. For: Nov 21 Filed by: Sender Gary
11/25
04:33 pm
ibio
Form 4 iBio, Inc. For: Nov 21 Filed by: Schimmelpennink Evert B.
Low
Report
Form 4 iBio, Inc. For: Nov 21 Filed by: Schimmelpennink Evert B.
11/25
04:33 pm
ibio
Form 4 iBio, Inc. For: Nov 21 Filed by: Kropotova Alexandra
Low
Report
Form 4 iBio, Inc. For: Nov 21 Filed by: Kropotova Alexandra
11/25
04:32 pm
ibio
Form 4 iBio, Inc. For: Nov 21 Filed by: Arkowitz David
Low
Report
Form 4 iBio, Inc. For: Nov 21 Filed by: Arkowitz David
11/25
04:32 pm
ibio
Form 4 iBio, Inc. For: Nov 21 Filed by: Clark William D
Low
Report
Form 4 iBio, Inc. For: Nov 21 Filed by: Clark William D
11/25
04:31 pm
ibio
Form 3 iBio, Inc. For: Nov 21 Filed by: Arkowitz David
Low
Report
Form 3 iBio, Inc. For: Nov 21 Filed by: Arkowitz David
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/2
iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference
41.4%
2/3 iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine 39.6%
2/28 Form S-3 iBio, Inc. 28.9%
8/19 iBio Inks 3D Bioprinting Agreement 28.6%
3/18 iBio Announces Development of Proprietary COVID-19 Vaccine Candidates 12.2%
8/26 iBio and CC-Pharming Expand Business Collaboration in China 10.5%
3/12 iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO 9.6%
2/25 Form 8-K/A iBio, Inc. For: Feb 20 9.5%
3/23 Form 4 iBio, Inc. For: Mar 17 Filed by: Isett Thomas Francis 3rd 6.9%
4/27 iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™ 6.7%
2/3 iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine 39.6%
2/28 Form S-3 iBio, Inc. 28.9%
8/19 iBio Inks 3D Bioprinting Agreement 28.6%
3/18 iBio Announces Development of Proprietary COVID-19 Vaccine Candidates 12.2%
8/26 iBio and CC-Pharming Expand Business Collaboration in China 10.5%
3/12 iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO 9.6%
2/25 Form 8-K/A iBio, Inc. For: Feb 20 9.5%
3/23 Form 4 iBio, Inc. For: Mar 17 Filed by: Isett Thomas Francis 3rd 6.9%
4/27 iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™ 6.7%
TOP News Decliners
10/25
iBio, Inc. Prices $5,000,000 Public Offering
-51.2%
3/2 Form DEFA14A iBio, Inc. -30.9%
10/24 Form S-1/A iBio, Inc. -27.4%
3/2 Thinking about buying stock in Aurora Cannabis, Chesapeake Energy Corp, FuelCell Energy, iBio, or Pinterest? -23.8%
3/9 Form 8-K iBio, Inc. For: Mar 05 -22.3%
8/20 Thinking about buying stock in Apache, CNH Industrial, Home Depot, Ibio, or Vivus? -20.4%
1/13 Form PRE 14A iBio, Inc. For: Feb 10 -18.2%
10/28 Form 8-K iBio, Inc. For: Oct 25 -16.5%
3/18 Form 8-K iBio, Inc. For: Mar 18 -15.4%
4/9 iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute -15.0%
3/2 Form DEFA14A iBio, Inc. -30.9%
10/24 Form S-1/A iBio, Inc. -27.4%
3/2 Thinking about buying stock in Aurora Cannabis, Chesapeake Energy Corp, FuelCell Energy, iBio, or Pinterest? -23.8%
3/9 Form 8-K iBio, Inc. For: Mar 05 -22.3%
8/20 Thinking about buying stock in Apache, CNH Industrial, Home Depot, Ibio, or Vivus? -20.4%
1/13 Form PRE 14A iBio, Inc. For: Feb 10 -18.2%
10/28 Form 8-K iBio, Inc. For: Oct 25 -16.5%
3/18 Form 8-K iBio, Inc. For: Mar 18 -15.4%
4/9 iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute -15.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: